Company / Operating Income
Regenerative Medical Technology Group Inc. Operating Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$867.2K
FY2025
5-year range
-$867.2K / $81.2K
FY2023-FY2025
Trend
-1168.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -1168% YoY in FY2025, a notable deviation from the 2-year average annual change of -528%.
Based on SEC 10-K filings.
-$867,162 in FY2025.
Declined from -$715,226 to -$867,162 over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 1168.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$867.2K | -1168.2% |
| FY2024 | $81.2K | +111.4% |
| FY2023 | -$715.2K | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026